Catalyst Wire Dossier Catalyst Wire Dossier

Ketorolac ophthalmic solution

Ketorolac
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ketorolac ophthalmic solution, covering 2012-08-13 to 2014-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration [Phase 4]

See pricing